Our Impact

Cure SMA Contributes Article to a Special Issue of the Journal Gene Therapy

September 28, 2017
Posted in , ,

To celebrate the FDA approval of Spinraza, Cure SMA contributed an article to the September special issue of the journal Gene Therapy. The issue , […]

Read More ›

Centers for Medicare and Medicaid Services (CMS) Survey

August 15, 2017
Posted in ,

On August 3rd, as part of multiple days of advocacy visits, Cure SMA staff met with leaders from the Medicare division of the Centers for […]

Read More ›

SMA Families and Cure SMA Staff Visit Capitol Hill for Advocacy Efforts

August 10, 2017
Posted in , ,

On August 2nd, members of the spinal muscular atrophy community kicked off SMA Awareness Month by meeting with a dozen Senate and House congressional offices […]

Read More ›

RUSP Nomination for SMA Accepted into Evidence Review

May 11, 2017
Posted in , ,

The Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children (SACHDNC) announced that they have accepted spinal muscular atrophy into the review process for […]

Read More ›

SMA Community’s Voice Heard “Loud and Clear” at Last Week’s Patient Focused Drug Development Meeting with the FDA

April 23, 2017
Posted in , ,

On April 18, 2017, the SMA community—families, clinicians, researchers, industry and regulators—gathered for a Patient-Focused Drug Development (PFDD) Meeting with the FDA. As part of […]

Read More ›

Cure SMA Awards $140,000 Grant to Arthur Burghes, PhD, The Ohio State University

March 15, 2017
Posted in , ,

Cure SMA has awarded a $140,000 research grant to Arthur Burghes, PhD, at The Ohio State University, for his project, “Identification of SMA modifiers and […]

Read More ›

SMA is Submitted to the Federal Newborn Recommended Uniform Screening Panel (RUSP)

March 1, 2017
Posted in , ,

Cure SMA and the SMA Newborn Screening Coalition are excited to announce we have completed the submission of SMA to the Recommended Uniform Screening Panel […]

Read More ›

Registration Opens for the SMA Patient-Focused Drug Development Meeting with the FDA

February 2, 2017
Posted in , ,

Registration is now open for the SMA Patient-Focused Drug Development (PFDD) meeting with the FDA. The PFDD meeting will be held at the College Park […]

Read More ›

Cure SMA Assists Hundreds of Families in 2016

January 6, 2017
Posted in , ,

Each year, Cure SMA provides thousands of families with vital support and resources to help them live active, engaged and hopeful lives.  Our programs provide […]

Read More ›

Cure SMA Funding Results in 16 New Research Publications

January 4, 2017
Posted in , ,

An important goal of our research funding strategy is to share scientific findings with the broader scientific community. To help accomplish this goal, scientists who […]

Read More ›
Scroll to Top